Zacks Company Profile for Biodesix, Inc. (BDSX : NSDQ) |
|
|
|
Company Description |
Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.
Number of Employees: 273 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $0.27 |
Daily Weekly Monthly
 |
20 Day Moving Average: 1,685,019 shares |
Shares Outstanding: 146.56 (millions) |
Market Capitalization: $39.81 (millions) |
Beta: 0.97 |
52 Week High: $2.04 |
52 Week Low: $0.17 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-3.62% |
-8.84% |
12 Week |
-52.35% |
-60.03% |
Year To Date |
-82.25% |
-83.37% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Scott Hutton - President; Chief Executive Officer
John Patience - Chairman and Director
Robin Harper Cowie - Chief Financial Officer; Secretary and Treasurer
Christopher C. Vazquez - Chief Accounting Officer
Jean Franchi - Director
|
|
Peer Information
Biodesix, Inc. (CHCR)
Biodesix, Inc. (ESRX)
Biodesix, Inc. (MYDP)
Biodesix, Inc. (COR)
Biodesix, Inc. (GBCS)
Biodesix, Inc. (LAXAF)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 09075X108
SIC: 8071
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
|
|
Share - Related Items
Shares Outstanding: 146.56
Most Recent Split Date: (:1)
Beta: 0.97
Market Capitalization: $39.81 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.06 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-0.25 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/06/25 |
|
|
|
|